14 October 19
Market up but early optimism fades (IPH, STO, FPH)
14 October 19
Market up but early optimism fades (IPH, STO, FPH)
14 October 19
Subscribers questions (FLT, IFM, PHB, CV1, GDX, JMS, PLS, FMG, NBI, MXT)
13 October 19
Market Matters Weekend Report Sunday 13th October 2019
11 October 19
ASX ends a choppy week on the right foot (PLS, FMG, PPT)
11 October 19
Are any ASX sectors showing their hand? (ORA, PNV, CUV)
10 October 19
All calm on the surface but plenty of action underneath – market closes unchanged (ORA, BSL)
10 October 19
Is it time to reconsider the embattled the lithium sector? (FLT, WEB, EEM US, LIT US, ORE, GXY, PLS)
09 October 19
Selling resumes following US trade escalation (FLT, CUV, CWY)
09 October 19
Income Report: Answering subscriber questions on Listed Investment Companies (LICs) + a new hybrid from CBA
09 October 19
Overseas Wednesday – International Equities & ETF Portfolios (NCM, GLEN LN, VALE US, FCX US, TTD US, DTYS US)
Yesterday following an explosive pre-market open by the US futures the ASX200 opened stronger than previously anticipated, up around 50-points. Unfortunately the sellers proceeded to take hold resulting in a fairly lacklustre day which saw the market close up a mere +0.25% with only 55% of stocks in the ASX200 managing to close in positive territory. The “Big 4” banks continued to perform strongly all closing positive on the day while the Energy and IT sectors were the most noticeable areas of weakness – we expected falls by the oil stocks following a plunge in the underlying commodity discussed yesterday but the IT stocks failing to follow the positive sector lead from Wall Street was a surprise e.g. Xero (XRO) -1.8%, Appen Ltd (APX) -1.4% and Altium (ALU) -1.4%.
The intra-day selling within the IT sector supports our opinion that the risk / reward towards the group suggests being patient - looking for lower prices remains the logical action e.g. Appen Ltd (APX) fell 6.3% from its positive open as investors clearly were comfortable to sell into strength. Our target area for this machine learning and artificial intelligence (AI) business remains ~8% lower. Interestingly the local IT sector has felt spooked of late while the US tech based NASDAQ remains firm closing overnight only 4% below its all-time high.
Short-term MM remains comfortable adopting a conservative stance towards equities around current market levels.
Overnight global stocks were firm enjoying continued optimism around US – China trade and another interest rate cut by the European Central Bank (ECB) to minus -0.5% plus it announced another round of QE through the purchase of bonds - The same old story but when will Europe finally show some green shoots of recovery. The SPI futures are pointing to an open up over 20-points with BHP and the resources sector looking poised for further gains.
This morning MM is going to look at the Healthcare sector which may be set for a period of underperformance if / when bond yields do bottom out.
Yesterday Fortescue (FMG) closed above $9 for the first time since the first week in July, its been an impressive 36% recovery by FMG considering iron ore has only bounced 19%. More noticeably FMG is back very close to its all time high, especially considering its recently traded ex-dividend, whereas the bulk commodity is languishing over 20% below its July high. We interpret this in 2 ways:
1 – The market never really believed the iron ore price around 800 was sustainable hence FMG didn’t get too carried away rallying above $9.
2 – FMG remains an excellent well positioned business whose anticipated 5.6% fully franked yield remains attractive, especially into stock weakness.
However we are conscious that the iron ore sector has largely recovered as MM has been calling it over recent months. If we reduce our exposure to the space its more likely to be through BHP or RIO, as opposed to FMG.
MM remains bullish FMG but cautious at current levels.
Iron Ore (CNY/Tonne) Chart
Fortescue Metals (FMG) Chart
Overnight saw a continuation of the rally by US bond yields on optimism around US – China trade, markets are certainly creating room for disappointment from the looming October trade talks in Washington. We would rather now buy dips in bond yields as opposed to sell rallies but as we approach the clear ~1.8% resistance area a strong pullback would not surprise.
Overall the down trend in US & global bond yields has been fairly dramatic in 2019 with many market followers anticipating a recession in the next 12-months i.e. about 60% of Americans now believe a recession is very likely in the near future. However as we saw last night with the ECB, global central banks are determined to maintain post GFC economic expansion at all costs, a job that in our opinion gets tougher every quarter e.g. the ECB dropping interest rates further into negative territory feels like a certain degree of almost panic our end.
On balance MM thinks US bond yields will at least test sub 1.5% one more time.
US 10-year Bond yield Chart
Interestingly, although Europe received the shot in the arm it was looking for with a rate cut plus more QE the reaction was pretty muted implying that much of the bullish influence was already priced into stocks.
On balance MM is now neutral European stocks.
German DAX Chart
How does the Healthcare sector look as Christmas approaches
The Australian Healthcare sector has been the classic “go to” space for many Australian investors both pre and post the GFC, a strategy that has undoubtedly paid excellent dividends. The sector has enjoyed 3 major macro-economic tailwinds:
1 – Both a growing and ageing Australian population.
2 – A weak Australian dollar which has suited many stocks in the sector that enjoy strong offshore earnings.
3 – Falling bond yields which has seen the Australian 10-year bond tumble from above 15% in the 1980’s to below 1% in the last few weeks.
At MM we feel the last 2 have almost finished delivering for the sector hence we pose the question, “is it time to take some $$ from the table?”. This time last year the sector was approaching its greatest sell-off in over a decade as investors and momentum traders alike dumped the high valuation / growth stocks, we put the possibility of a repeat performance at ~25% i.e. technically the sector looks very vulnerable to a retest of Q4 lows, now a significant +20% away.
MM is very cautious the Healthcare Sector at current levels.
ASX200 Healthcare Sector Chart
Today I have briefly looked at 5 stocks in the sector as the other high value / growth area the local IT sector starts to “wobble” after recently making fresh al-time highs.
MM is short-term bearish the local IT sector.
ASX200 Software & Services Index Chart
Today we have briefly looked at 5 Australian Healthcare stocks deliberately focusing on the big end of town, or the prime “go to “ candidates of recent years.
1 CSL Ltd (CSL) $231.60
Human blood plasma business CSL is arguably the most successful company in the ASX200, it’s become the second largest company on the bourse with a market cap of $105bn, only Commonwealth Bank is now larger with a market cap of $144bn. The company delivered a very strong result for the 2019 Financial Year (FY) showing an 11% increase in revenue to $US8.5bn leading to a 17% rise in Net Profit After Tax (NPAT) to almost $US2bn, a very impressive set of numbers for such a large business – an ideal candidate to buy into the next pullback.
However like most stocks it hasn’t been a straight line ascent with corrections of 25%, 18% and again 25% over the last 3-years alone, in other words this world quality business has often provided excellent opportunities for the investor to buy / accumulate stock. Technically the stock looks ok but it is threatening a repeat performance of Q4 2018 with sub $200 the potential target area – this is a world class business which MM is keen to again own, especially in its Platinum Portfolio, but from a risk / reward basis current levels feel simply too rich.
MM is neutral / negative CSL at current levels.
CSL Ltd (CSL) Chart
2 Cochlear (COH) $207.45
Hearing aid implant company COH looks and feels very similar to CSL. The company delivered a full year profit of ~$265m plus some bullish commentary but we note that its rivals gained some market share, never a good sign.
However technically COH is now generating sell signals as it breaks back below $220 with a target area over 10% lower.
MM is neutral / negative COH looking for ~10% downside.
Cochlear (COH) Chart
3 ResMed (RMD) $19.49
Sleeping disorder business RMD has rallied further and harder than we expected, a definite example of taking our $$ too early in 2019. The San Diego based business reported a profit of $US121 for the quarter under the 30th of June but it appears to be the strong sales figures of new product sales that’s sent the stock soaring in 2019.
Technically the stock looks ready for a period of rotation between around $18.50 and $20.50.
MM is neutral RMD.
ResMed (RMD) Chart
4 Ansell Ltd (ANN) $27.58
Health and Safety business ANN is trading at the same level as back in 2015, its recent profit numbers were solid showing sales up slightly to almost $1.5bn while the company announced a buyback of just over 10m shares.
Technically the stock remains neutral with a slight positive bias.
MM is neutral ANN.
Ansell Ltd (ANN) Chart
5 Pro Medicus Ltd (PME) $29.68
New stock off the block PME provides software & IT solutions for the medical industry, its clearly enjoyed an extraordinary run in 2019 rallying by 4-fold. However the stock tumbled last week after significant sales of shares by 2 of the company’s founders – who can blame them after the share price appreciation. However it should be noted they only sold 3.5% of their holdings, in other words they still have plenty of skin the game. Also it should be noted that the board encouraged the sale to add some liquidity to the stock.
The current sell-off feels like a buying opportunity if it continues down towards $25.
MM is short-term negative PME targeting the $25 area.
Pro Medicus Ltd (PME) Chart
MM is unlikely to buy stocks in the Healthcare sector at current levels believing there is a reasonable possibility of a repeat performance of Q4 2018 i.e. an aggressive decline by the sector.
No major change yet, we are looking for a decent pullback for US stocks but no specific sell signals have been triggered – note at the moment we still feel a break to fresh all-time highs will fail to aggressively follow through to the upside.
US stocks will generate a short-term sell signal if the NASDAQ breaks the uptrend line shown below in blue.
US NASDAQ Index Chart
No change again with European indices, while we remain cautious European stocks as their tone has become more bearish over the last few months, however we had been targeting a correction of at least 5% for the broad European indices, this has now been achieved.
The long-term trend is up hence any “short squeezes” might be harder and longer than many anticipate, potentially one is currently unfolding.
Euro Stoxx 50 Chart
Overnight Market Matters Wrap
· The SPI is up 22 points after more gains in US equities overnight. The Dow rose for the seventh successive session, up 0.2%, while the S&P 500 is getting close to an all-time high, +0.3%. The NASDAQ also closed 0.3% in the black.
· Mario Draghi, the head of the ECB, announced the resumption of quantitative easing and cut its key interest rate to a record low. US-China trade tensions continue to ease with talks of an interim deal and a roll-back of some US tariffs in exchange for IP commitments and agricultural purchases.
· Trump wasn’t happy that the ECB is cutting rates and depreciating the Euro as it puts upward pressure on the $US and hurts the US ability to export. He continued his attack on the Fed by saying they are just sitting around while the Europeans get paid to borrow money.
· Nickel and copper rose on the LME, while aluminium fell. Iron ore rose 5% to trade close to $US100/t while gold is at $US1500/oz. Oil fell after OPEC+ applied more pressure on members who haven’t complied with cuts.
Have a great day!
James & the Market Matters Team
Market Matters may hold stocks mentioned in this report. Subscribers can view a full list of holdings on the website by clicking here. Positions are updated each Friday, or after the session when positions are traded.
All figures contained from sources believed to be accurate. All prices stated are based on the last close price at the time of writing unless otherwise noted. Market Matters does not make any representation of warranty as to the accuracy of the figures or prices and disclaims any liability resulting from any inaccuracy.
Reports and other documents published on this website and email (‘Reports’) are authored by Market Matters and the reports represent the views of Market Matters. The Market Matters Report is based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.
The Reports contain general, as opposed to personal, advice. That means they are prepared for multiple distributions without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor. Market Matters or its author(s) accepts no responsibility for any losses or damages resulting from decisions made from or because of information within this publication. Investing and trading in financial products are always risky, so you should do your own research before buying or selling a financial product.
The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports. Market Matters may publish content sourced from external content providers.
If you rely on a Report, you do so at your own risk. Past performance is not an indication of future performance. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.
Financial Services Guide
Date prepared: Wednesday, 22 November 2017
Last update: Friday, 23rd April 2019
About this Financial Services Guide (FSG)
This FSG provides you with key information about a range of subscription services offered by:
Marketmatters Pty Ltd (Market Matters) Australian Financial Services Licence No. 488798 ABN (20 137 462 536)
Level 29, Chifley Tower, 2 Chifley Square Sydney 2000
T: 1300 301 868
E: [email protected]
In this FSG, “we”, us” and “our” refer to Market Matters.
Market Matters holds Australian Financial Services Licence No. 488798 (AFSL) and is responsible for any financial services that we provide to you.
This AFSL was issued on 8th September 2016.
The purpose of this FSG is to provide you with information about:
Market Matters operates a website, www.marketmatters.com.au (Website), where customers may, for the payment of a subscription fee, access certain financial information and general advice. In particular, the Website provides:
This FSG relates only to the Website Services.
What financial services we can offer in connection with the Website Services
As holder of AFSL number 488798, in connection with the Website Services we are authorised to provide general financial product advice to both retail and wholesale clients in relation to the following financial products:
The Website Services are comprised of general advice only. That is, none of the advice given on the Website or by provision of the Website Services takes into account any of your objectives, financial situation or needs (Your Personal Circumstances). Before acting on any of the information, advice or Website Services, you must consider the appropriateness of this information in light of Your Personal Circumstances and, if necessary, consult a financial adviser before making any investment decision.
If you are seeking to acquire a specific financial product or security, you should obtain a copy of and consider the Product Disclosure Statement or Prospectus for that product before making any investment decision.
The Website does not provide a trading platform or access to a trading platform. There is no ability to purchase or sell financial products through the Website.
How do I access these services?
You can access these services by going to www.marketmatters.com.au and following the prompts and steps required to sign up for membership. Please read all terms and conditions carefully.
Fees and benefits payable to us and our associates
The Website is a subscription-based service. A yearly fixed subscription fee is payable to Market Matters when you subscribe to the Website which will vary depending on the type of subscription for which you subscribe. At the date of this FSG, the yearly subscription fees are as follows:
Platinum: $1,238 for 12 months
Platinum: $1,993 for 24 months
Subscription fees vary from time to time and are provided on the Website.
The Website does not currently feature third party advertising. Market Matters reserve the right to advertise at a future time for which they may receive remuneration. Any such advertising will be independent of any other content on the Website.
All representatives of Market Matters (Market Matters Staff) receive a salary paid by Market Matters. Market Matters Staff may also receive performance-based bonuses which are based on profitability, the number of subscribers and subscription renewal rates.
How do we manage potential conflicts of interest?
Market Matters have implemented policies and procedures to mitigate the risk of conflicts of interest. These include:
Market Matters Staff and Contributors are encouraged to express independent views and opinions on the topics they write about. This is established through ongoing training, external audits and our conflict of interest and staff trading policies. Market Matters Staff are required to serve the best interests of the subscribers, without consideration of any commercial or personal interests.
How is my personal information dealt with?
If you have a complaint about our services, you should take the following steps:
Contact us and discuss the complaint directly. If you do not feel comfortable discussing the complaint with us or your complaint is not satisfactorily resolved within 2 business days, please telephone Market Matters, on 1300 301 868 and ask to speak with the Complaints Officer. We suggest you put your complaint in writing at this time so that the issues are fully documented and understood by the parties. Your complaint should be addressed to:
The Complaints Officer
Level 29, Chifley Tower,
2 Chifley Square Sydney NSW 2000
Market Matters will review your complaint within 45 days and attempt resolution. If you are still not satisfied with the outcome, you may take your complaint to an external dispute resolution scheme. Market Matters is a member of the scheme operated by the Financial Ombudsman Service. You should write to:Australian Financial Complaints Authority Limited (AFCA)
You may also wish to consult ASIC in relation to your complaint. ASIC’s website contains information on complaining about companies and people and describes the types of complaints handled by ASIC. You can contact ASIC on its free call infoline:
Tel: 1300 300 630 or email [email protected]
We maintain professional indemnity insurance to cover our employees and Authorised Representatives (including us) for the financial services they provide, having regard to the following:
If you require further information about these compensation arrangements please contact us.
Terms and Conditions
This website, www.marketmatters.com.au, is published by Marketmatters Pty Limited (ABN 20 137 462 536) ('Market Matters', 'MM', 'us', 'we', 'our') Australian Financial Services Licence 488798
Financial Services Guide
Market Matters Financial Services Guide (FSG) is located here, and contains important information about the financial services provided by Market Matters. You must read our FSG and consider it in the context of your Personal Circumstances before acting on any advice. By accepting the terms and conditions you are acknowledging that you have read the FSG.
Provision of the Reports
Reports and other documents published on the Market Matter’s website (‘Reports’) are authored by Market Matters. The Reports represent the views of Market Matters based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.
The Reports contain general, as opposed to personal advice. That means they are prepared for multiple distribution without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor.
The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports.
If you rely on a Report, you do so at your own risk. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.
Past performance is not a reliable indicator of future results. Brokerage costs have not been included in the calculation of performance. As financial products rise and fall in value, returns may be negative. Performance figures are not intended to be a forecast. Market Matters does not guarantee the performance of or returns on any investment.
Employees and/or associates of Market Matters may hold one or more of the stocks reviewed on this website.
Subscriptions and Subscription Prices
To access premium content available on the Market Matters website you may initially subscribe through the complimentary trial which provides you full access to all services for the trial period. You are limited to two trials after which you must subscribe to one or more membership categories available on the website or direct with Market Matters before you can trial the service again, three months after the expiry of your second trial.
To subscribe to Market Matters services and access to the website you may go to the Memberships page of the website, provide the information marked as ‘Mandatory’ and select the payment option for the price quoted (at the time of your transaction) or contact the team directly at Market Matters by phone or email. You will then receive a verification email from Market Matters indicating that your subscription and payment have been accepted and you will be able to access the premium content.
Prices published on the Market Matters website are quoted in Australian Dollars (AUD) and are inclusive of GST and/or all other duties and taxes. Market Matters has used reasonable endeavours to ensure that prices for subscription to its services are published accurately on the website but these prices are subject to change and Market Matters reserves the right to change these prices and will notify you of any increase by email (with the price increase to apply from the time the next payment is due).
Marketmatters Pty Ltd (ABN 20 137 462 536) will issue a tax invoice to paying subscribers in relation to any supply that is subject to GST in accordance with A New Tax System (Goods and Services Tax) Act 1999.
Any member is entitled to cancel their membership at any time. In the event a member does wish to cancel their subscription, cancellations must be notified in writing to:
Level 29, Chifley Tower, 2 Chifley Square, Sydney NSW 2000
or by email to: [email protected]
All cancellations of month-by-month subscriptions will be cancelled and not billed again the following month.
All cancellations within 14 days we be entitled to a full refund. Any introductory gifts, such as, but not limited to; iPads, Fitbit watches, Apple watches, Google Homes, must be returned in their original condition before a refund will be made.
All cancellations made after 14 days of subscription commencement will not be entitled to a refund unless in the event of extenuating circumstances, at the sole discretion of Market Matters.
Subscriptions will automatically renew on the expiry date of current subscription. In these instances the subscription will be renewed at the current rate published on the Market Matters web site, using the same credit card that paid for the initial subscription, unless otherwise requested by the subscriber. A subscriber who wishes to cancel after being renewed in this way will have a “14 day cooling off period” in which they can request to discontinue and will receive a full refund for the renewal payment, this can be done in writing to:
Level 29, Chifley Tower, 2 Chifley Square Sydney 2000
or by email to: [email protected]
Market Matters has not reviewed any of the websites which link to this website or to which this website links. Market Matters is not responsible for the content of any other website or pages linked to or linking to its website. Following links to any other websites or pages shall be at the user’s own risk.
Copyright © 2018 Marketmatters Pty Ltd (ABN 20 137 462 536). No part of this website, or its content, may be reproduced in any form without the prior consent of Market Matters.
This Agreement is governed by and is to be construed in accordance with the laws of New South Wales, Australia. You agree to the non-exclusive jurisdiction of the courts of New South Wales, Australia in respect of any proceedings concerning this Agreement. This website is not available to US and/or EU persons and by accepting these terms you confirm that you are not a US and/or EU person.